https://www.bioworld.com/rss en-us http://www.bioworld.com/articles/730618 Fri, 24 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730618-anaptysbios-spinout-first-tracks-hits-the-slopes Drug R&D concept image. BioWorld. Remedy is taking a secretome-based approach to treat lung disorders, having moved its lead asset, RC-0315, into a first-in-human clinical trial for idiopathic pulmonary fibrosis (IPF) in January. ]]> http://www.bioworld.com/articles/730576 Tue, 21 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730576-remedy-pushes-cell-free-secretome-therapy-for-ipf-into-phase-i Ayele Dilion Mashiah, CEO, Remedy Ayelet Dilion Mashiah, CEO, Remedy Cell Ltd. http://www.bioworld.com/articles/730482 Tue, 21 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730482-tortugas-launches-with-106m-for-neurology-neuropsychiatric-drugs Jeff Jonas, CEO and Al Robichaud, president, head of R&D, Tortugas Neuroscience Tortugas Neuroscience Inc. is led by Jeff Jonas, CEO (left), and Al Robichaud, president and head of R&D. BioWorld. Remedy is taking a secretome-based approach to treat lung disorders, having moved its lead asset, RC-0315, into a first-in-human clinical trial for idiopathic pulmonary fibrosis (IPF) in January. Secretomes refer to the collection of bioactive molecules secreted by cells in the extracellular space, including proteins, enzymes, growth factors and extracellular vesicles such as exosomes.]]> http://www.bioworld.com/articles/730310 Wed, 15 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730310-remedy-pushes-cell-free-secretome-therapy-for-ipf-into-phase-i Ayele Dilion Mashiah, CEO, Remedy Ayelet Dilion Mashiah, CEO, Remedy Cell Ltd. http://www.bioworld.com/articles/730420 Tue, 14 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730420-new-china-biotech-syneron-chases-macrocycle-frontier Multicolor peptide illustration BioWorld. “The goal is to reset the immune system rather than continuously suppress it, and we believe we have a unique technology to do that.”]]> http://www.bioworld.com/articles/730296 Tue, 14 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730296-immune-reset-is-ambition-of-tr1xs-allogenic-tr1-cell-therapy Cell therapy illustration http://www.bioworld.com/articles/730228 Fri, 10 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730228-realta-secures-another-40m-for-its-hypoxic-ischemic-encephalopathy-treatment Photo of hands holding a baby http://www.bioworld.com/articles/730275 Thu, 09 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730275-sidewinders-bispecific-adc-approach-draws-137m-series-b Blue digital dollar sign http://www.bioworld.com/articles/730152 Wed, 08 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730152-new-china-biotech-syneron-chases-macrocycle-frontier Multicolor peptide illustration http://www.bioworld.com/articles/730148 Wed, 08 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730148-sidewinders-bispecific-adc-approach-draws-137m-series-b Blue digital dollar sign http://www.bioworld.com/articles/730256 Wed, 08 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730256-sononeu-wins-52m-arpa-h-grant-for-ultrasound-activated-therapeutics Neuropathy illustrated in legs and feet http://www.bioworld.com/articles/730136 Tue, 07 Apr 2026 11:00:00 -0400 https://www.bioworld.com/articles/730136-sononeu-wins-52m-arpa-h-grant-for-ultrasound-activated-therapeutics Neuropathy illustrated in legs and feet http://www.bioworld.com/articles/730206 Tue, 07 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730206-stipple-launches-with-100m-for-novel-oncology-targets Dollar sign in light bulb on yellow background http://www.bioworld.com/articles/730120 Mon, 06 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730120-stipple-launches-with-100m-for-novel-oncology-targets Dollar sign in light bulb on yellow background http://www.bioworld.com/articles/730118 Mon, 06 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730118-one-carbon-has-new-approach-to-starving-tumors-of-nucleotides Blue cancer cell http://www.bioworld.com/articles/730076 Thu, 02 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730076-ambrosia-slurps-up-a-100m-series-b-for-its-oral-obesity-drug-pipeline Pills, bottle, scale and-measuring tape http://www.bioworld.com/articles/729898 Tue, 24 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729898-excalipoint-closes-687m-seed-round-for-cancer-t-cell-engagers Blue-gray dollar sign http://www.bioworld.com/articles/729825 Tue, 24 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729825-immutrin-raises-65m-series-a-to-take-another-run-at-reversing-amyloidosis Heart scientific overlay http://www.bioworld.com/articles/729809 Mon, 23 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729809-oryon-emerges-with-autologous-stem-cell-therapy-for-parkinsons Parkinson's disease illustration showing neurons containing alpha-synuclein http://www.bioworld.com/articles/729788 Thu, 19 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/729788-excalipoint-closes-687m-seed-round-for-cancer-t-cell-engagers Blue-gray dollar sign http://www.bioworld.com/articles/729560 Wed, 18 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729560-excalipoint-closes-687m-seed-round-for-cancer-t-cell-engagers Blue-gray dollar sign http://www.bioworld.com/articles/729706 Tue, 17 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/729706-enodia-jumps-ahead-in-sec61-targeting-adds-kezars-program Tinted Euro symbol http://www.bioworld.com/articles/729551 Tue, 17 Mar 2026 08:00:00 -0400 https://www.bioworld.com/articles/729551-r1s-775m-series-a-to-fund-ckd-trial-of-oral-phosphate-inhibitor Kidneys http://www.bioworld.com/articles/729529 Mon, 16 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729529-enodia-jumps-ahead-in-sec61-targeting-adds-kezars-program Tinted Euro symbol http://www.bioworld.com/articles/729687 Mon, 16 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/729687-kyron-servier-deal-focused-on-programmable-glycoprotein-platform Drug R&D concept image. http://www.bioworld.com/articles/729494 Fri, 13 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729494-kyron-servier-deal-focused-on-programmable-glycoprotein-platform Drug R&D concept image. http://www.bioworld.com/articles/729238 Tue, 24 Feb 2026 11:00:00 -0500 https://www.bioworld.com/articles/729238-harbour-biomed-spins-out-newco-in-12b-ctla-4-deal Illustration of CTLA-4 protein structure http://www.bioworld.com/articles/729231 Tue, 24 Feb 2026 11:00:00 -0500 https://www.bioworld.com/articles/729231-quantx-raises-85m-to-advance-oral-immunology-drugs Interleukin 17 (IL-17) http://www.bioworld.com/articles/729229 Tue, 24 Feb 2026 11:00:00 -0500 https://www.bioworld.com/articles/729229-omnigeniqs-journey-from-space-science-to-drug-design 3D illustration of a chain of amino acid or biomolecules called protein http://www.bioworld.com/articles/729227 Tue, 24 Feb 2026 09:00:00 -0500 https://www.bioworld.com/articles/729227-vesalic-targeting-toxic-muscle-exosomes-in-motor-neuron-diseases Neural network